Hydrocephalus after aSAH can be classified based on **timing** and **pathophysiology**: This condition can present in acute, subacute, or chronic forms: [[Acute hydrocephalus]] (within 72 hours of hemorrhage) results from obstruction of CSF pathways by blood clots or impaired absorption at the arachnoid granulations. ---- [[Subacute hydrocephalus]] (occurs within days to weeks) is often due to persistent inflammation and clot organization. ---- [[Chronic hydrocephalus]] (develops weeks to months later) is usually a communicating hydrocephalus caused by scarring and fibrosis affecting CSF resorption. 1. **Acute Hydrocephalus (within 3 days of aSAH)** - Caused by obstruction of CSF flow due to **blood clots in the basal cisterns or ventricles**. - Can be **communicating** (impaired absorption at the arachnoid granulations) or **non-communicating** (obstructed CSF pathways, e.g., at the Sylvian aqueduct or fourth ventricle outlets). - Often manifests as **altered consciousness, headache, vomiting, and pupillary abnormalities**. - Treatment: External ventricular drainage (EVD) to relieve pressure and allow for CSF diversion. 2. **Subacute Hydrocephalus (4–14 days post-aSAH)** - Thought to result from ongoing inflammation and dysfunction of CSF absorption. - Patients may develop **progressive confusion, gait disturbances, and urinary incontinence**. - Treatment: Persistent hydrocephalus after EVD removal may require **lumbar drainage or shunt placement**. 3. **Chronic Hydrocephalus (>14 days post-aSAH)** - Typically **communicating hydrocephalus**, caused by scarring and fibrosis at the arachnoid granulations. - Presents insidiously with **cognitive decline, gait ataxia, and urinary urgency/incontinence**, resembling **normal pressure hydrocephalus (NPH)**. - Treatment: **Permanent CSF diversion** with a ventriculoperitoneal (VP) or ventriculoatrial (VA) shunt. ## **Risk Factors for Hydrocephalus After aSAH** Several factors increase the likelihood of hydrocephalus after aSAH: - **Higher Fisher grade (thick cisternal blood and IVH)** → greater inflammatory response and CSF obstruction. - **Intraventricular hemorrhage (IVH)** → direct obstruction of CSF flow. - **Older age** → reduced CSF resorption capacity. - **Female sex** → associated with a higher risk in some studies. - **Poor clinical grade (Hunt-Hess or WFNS score)** → higher initial brain injury burden. - **Aneurysm location (e.g., anterior communicating artery aneurysm)** → increased risk of basal cistern blood clotting. ## **Diagnosis** - **CT Scan (Initial Modality)**: Enlarged **temporal horns**, **third ventricle**, and **sylvian fissures** with periventricular lucency (suggesting transependymal CSF flow). - **MRI with FLAIR and Cine Flow Studies**: Useful in chronic cases. - **Lumbar Puncture (Caution Required)**: Can confirm communicating hydrocephalus but should be avoided in **high-pressure states** to prevent herniation. ## **Prognosis and Outcomes** - Hydrocephalus after aSAH is associated with **worse functional outcomes**. - Persistent hydrocephalus requiring shunting occurs in **~10-20% of cases**. - **Early recognition and intervention improve functional recovery**. ## **Conclusion** Hydrocephalus is a significant complication of aSAH, requiring **timely diagnosis and appropriate management**. Understanding the risk factors and clinical course is essential to improving **neurological outcomes and quality of life** for these patients. ----